Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Cash from Financing Activities (2022 - 2023)

Historic Cash from Financing Activities for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $100.1 million.

  • Lexeo Therapeutics' Cash from Financing Activities rose 12364444.44% to $100.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $103.8 million, marking a year-over-year change of. This contributed to the annual value of $88.8 million for FY2024, which is 1446.66% down from last year.
  • As of Q4 2023, Lexeo Therapeutics' Cash from Financing Activities stood at $100.1 million, which was up 12364444.44% from $3.9 million recorded in Q3 2023.
  • Lexeo Therapeutics' 5-year Cash from Financing Activities high stood at $100.1 million for Q4 2023, and its period low was -$98000.0 during Q1 2023.